Serveur d'exploration sur le lymphœdème

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Adjuvant radiotherapy following radical hysterectomy for patients with stage IB and IIA cervical cancer

Identifieur interne : 00DB52 ( Main/Exploration ); précédent : 00DB51; suivant : 00DB53

Adjuvant radiotherapy following radical hysterectomy for patients with stage IB and IIA cervical cancer

Auteurs : Andrew P. Soisson [États-Unis] ; John T. Soper [États-Unis] ; Daniel L. Clarke-Pearson [États-Unis] ; Andrew Berchuck [États-Unis] ; Gustavo Montana [États-Unis] ; William T. Creasman [États-Unis]

Source :

RBID : ISTEX:F19985DBDAC8C2D380C119DFF422A88A3C64BF5B

Descripteurs français

English descriptors

Abstract

From 1971 through 1984, 320 women underwent radical hysterectomy as primary therapy of stage IB and IIA cervical cancer. Two hundred forty-eight patients (78%) were treated with surgery alone and 72 patients (22%) received adjuvant postoperative external-beam ratiotherapy. Presence of lymph node metastasis, large lesion (>4 cm in diameter), histologic grade, race (non-caucasian), and age (>40 years) were significant poor prognostic factors for the entire group of patients. Patients treated with surgery alone had a better disease-free survival than those who received combination therapy (P < 0.001). However, patients receiving adjuvant radiation therapy had a higher incidence of lymphatic metastases, tumor involvement of the surgical margin, and large cervical lesions. Adjuvant pelvic radiation therapy did not improve the survival of patients with unilateral nodal metastases or those who had a large cervical lesion with free surgical margins and the absence of nodal involvement. Radiation therapy appears to reduce the incidence of pelvic recurrences. Unfortunately, 84% of patients who developed recurrent tumor after combination therapy had a component of distant failure. The incidence of severe gastrointestinal or genitourinary tract complications was not different in the two treatment groups. However, the incidence of lymphedema was increased in patients who received adjuvant radiation therapy. Although adjuvant radiation therapy appears to be tolerated without a significant increase in serious complications, the extent to which it may improve local control rates and survival in high-risk patients appears to be limited. In view of the high incidence of distant metastases in high-risk patients, consideration should be given to adjuvant systemic chemotherapy in addition to radiation therapy.

Url:
DOI: 10.1016/0090-8258(90)90374-T


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title>Adjuvant radiotherapy following radical hysterectomy for patients with stage IB and IIA cervical cancer</title>
<author>
<name sortKey="Soisson, Andrew P" sort="Soisson, Andrew P" uniqKey="Soisson A" first="Andrew P." last="Soisson">Andrew P. Soisson</name>
</author>
<author>
<name sortKey="Soper, John T" sort="Soper, John T" uniqKey="Soper J" first="John T." last="Soper">John T. Soper</name>
</author>
<author>
<name sortKey="Clarke Pearson, Daniel L" sort="Clarke Pearson, Daniel L" uniqKey="Clarke Pearson D" first="Daniel L." last="Clarke-Pearson">Daniel L. Clarke-Pearson</name>
</author>
<author>
<name sortKey="Berchuck, Andrew" sort="Berchuck, Andrew" uniqKey="Berchuck A" first="Andrew" last="Berchuck">Andrew Berchuck</name>
</author>
<author>
<name sortKey="Montana, Gustavo" sort="Montana, Gustavo" uniqKey="Montana G" first="Gustavo" last="Montana">Gustavo Montana</name>
</author>
<author>
<name sortKey="Creasman, William T" sort="Creasman, William T" uniqKey="Creasman W" first="William T." last="Creasman">William T. Creasman</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:F19985DBDAC8C2D380C119DFF422A88A3C64BF5B</idno>
<date when="1990" year="1990">1990</date>
<idno type="doi">10.1016/0090-8258(90)90374-T</idno>
<idno type="url">https://api.istex.fr/document/F19985DBDAC8C2D380C119DFF422A88A3C64BF5B/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">007130</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">007130</idno>
<idno type="wicri:Area/Istex/Curation">007130</idno>
<idno type="wicri:Area/Istex/Checkpoint">005511</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">005511</idno>
<idno type="wicri:doubleKey">0090-8258:1990:Soisson A:adjuvant:radiotherapy:following</idno>
<idno type="wicri:Area/Main/Merge">00E762</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:2351324</idno>
<idno type="wicri:Area/PubMed/Corpus">005D50</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">005D50</idno>
<idno type="wicri:Area/PubMed/Curation">005D50</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">005D50</idno>
<idno type="wicri:Area/PubMed/Checkpoint">005D50</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">005D50</idno>
<idno type="wicri:Area/Ncbi/Merge">005722</idno>
<idno type="wicri:Area/Ncbi/Curation">005722</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">005722</idno>
<idno type="wicri:doubleKey">0090-8258:1990:Soisson A:adjuvant:radiotherapy:following</idno>
<idno type="wicri:Area/Main/Merge">00E676</idno>
<idno type="wicri:Area/Main/Curation">00DB52</idno>
<idno type="wicri:Area/Main/Exploration">00DB52</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a">Adjuvant radiotherapy following radical hysterectomy for patients with stage IB and IIA cervical cancer</title>
<author>
<name sortKey="Soisson, Andrew P" sort="Soisson, Andrew P" uniqKey="Soisson A" first="Andrew P." last="Soisson">Andrew P. Soisson</name>
<affiliation wicri:level="1">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Duke University Medical Center, Durham, North Carolina 27710</wicri:regionArea>
<wicri:noRegion>North Carolina 27710</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Soper, John T" sort="Soper, John T" uniqKey="Soper J" first="John T." last="Soper">John T. Soper</name>
<affiliation wicri:level="1">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Duke University Medical Center, Durham, North Carolina 27710</wicri:regionArea>
<wicri:noRegion>North Carolina 27710</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Clarke Pearson, Daniel L" sort="Clarke Pearson, Daniel L" uniqKey="Clarke Pearson D" first="Daniel L." last="Clarke-Pearson">Daniel L. Clarke-Pearson</name>
<affiliation wicri:level="1">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Duke University Medical Center, Durham, North Carolina 27710</wicri:regionArea>
<wicri:noRegion>North Carolina 27710</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Berchuck, Andrew" sort="Berchuck, Andrew" uniqKey="Berchuck A" first="Andrew" last="Berchuck">Andrew Berchuck</name>
<affiliation wicri:level="1">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Duke University Medical Center, Durham, North Carolina 27710</wicri:regionArea>
<wicri:noRegion>North Carolina 27710</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Montana, Gustavo" sort="Montana, Gustavo" uniqKey="Montana G" first="Gustavo" last="Montana">Gustavo Montana</name>
<affiliation wicri:level="1">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Radiation Oncology, Division of Gynecologic Oncology, Duke University Medical Center, Durham, North Carolina 27710</wicri:regionArea>
<wicri:noRegion>North Carolina 27710</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Creasman, William T" sort="Creasman, William T" uniqKey="Creasman W" first="William T." last="Creasman">William T. Creasman</name>
<affiliation wicri:level="1">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Obstetrics and Gynecology, Medical University of South Carolina, Charleston, South Carolina 29425</wicri:regionArea>
<wicri:noRegion>South Carolina 29425</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Gynecologic Oncology</title>
<title level="j" type="abbrev">YGYNO</title>
<idno type="ISSN">0090-8258</idno>
<imprint>
<publisher>ELSEVIER</publisher>
<date type="published" when="1990">1990</date>
<biblScope unit="volume">37</biblScope>
<biblScope unit="issue">3</biblScope>
<biblScope unit="page" from="390">390</biblScope>
<biblScope unit="page" to="395">395</biblScope>
</imprint>
<idno type="ISSN">0090-8258</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0090-8258</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adolescent</term>
<term>Adult</term>
<term>Aged</term>
<term>Combined Modality Therapy</term>
<term>Female</term>
<term>Humans</term>
<term>Hysterectomy (methods)</term>
<term>Lymph Nodes (pathology)</term>
<term>Lymphatic Metastasis</term>
<term>Lymphedema (etiology)</term>
<term>Middle Aged</term>
<term>Neoplasm Recurrence, Local</term>
<term>Radiation Injuries</term>
<term>Survival Analysis</term>
<term>Uterine Cervical Neoplasms (mortality)</term>
<term>Uterine Cervical Neoplasms (radiotherapy)</term>
<term>Uterine Cervical Neoplasms (surgery)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Adolescent</term>
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Analyse de survie</term>
<term>Association thérapeutique</term>
<term>Femelle</term>
<term>Humains</term>
<term>Hystérectomie ()</term>
<term>Lymphoedème (étiologie)</term>
<term>Lésions radio-induites</term>
<term>Métastase lymphatique</term>
<term>Noeuds lymphatiques (anatomopathologie)</term>
<term>Récidive tumorale locale</term>
<term>Sujet âgé</term>
<term>Tumeurs du col de l'utérus ()</term>
<term>Tumeurs du col de l'utérus (mortalité)</term>
<term>Tumeurs du col de l'utérus (radiothérapie)</term>
</keywords>
<keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr">
<term>Noeuds lymphatiques</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en">
<term>Lymphedema</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en">
<term>Hysterectomy</term>
</keywords>
<keywords scheme="MESH" qualifier="mortality" xml:lang="en">
<term>Uterine Cervical Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="mortalité" xml:lang="fr">
<term>Tumeurs du col de l'utérus</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en">
<term>Lymph Nodes</term>
</keywords>
<keywords scheme="MESH" qualifier="radiotherapy" xml:lang="en">
<term>Uterine Cervical Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="radiothérapie" xml:lang="fr">
<term>Tumeurs du col de l'utérus</term>
</keywords>
<keywords scheme="MESH" qualifier="surgery" xml:lang="en">
<term>Uterine Cervical Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="étiologie" xml:lang="fr">
<term>Lymphoedème</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Adolescent</term>
<term>Adult</term>
<term>Aged</term>
<term>Combined Modality Therapy</term>
<term>Female</term>
<term>Humans</term>
<term>Lymphatic Metastasis</term>
<term>Middle Aged</term>
<term>Neoplasm Recurrence, Local</term>
<term>Radiation Injuries</term>
<term>Survival Analysis</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Adolescent</term>
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Analyse de survie</term>
<term>Association thérapeutique</term>
<term>Femelle</term>
<term>Humains</term>
<term>Hystérectomie</term>
<term>Lésions radio-induites</term>
<term>Métastase lymphatique</term>
<term>Récidive tumorale locale</term>
<term>Sujet âgé</term>
<term>Tumeurs du col de l'utérus</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">From 1971 through 1984, 320 women underwent radical hysterectomy as primary therapy of stage IB and IIA cervical cancer. Two hundred forty-eight patients (78%) were treated with surgery alone and 72 patients (22%) received adjuvant postoperative external-beam ratiotherapy. Presence of lymph node metastasis, large lesion (>4 cm in diameter), histologic grade, race (non-caucasian), and age (>40 years) were significant poor prognostic factors for the entire group of patients. Patients treated with surgery alone had a better disease-free survival than those who received combination therapy (P < 0.001). However, patients receiving adjuvant radiation therapy had a higher incidence of lymphatic metastases, tumor involvement of the surgical margin, and large cervical lesions. Adjuvant pelvic radiation therapy did not improve the survival of patients with unilateral nodal metastases or those who had a large cervical lesion with free surgical margins and the absence of nodal involvement. Radiation therapy appears to reduce the incidence of pelvic recurrences. Unfortunately, 84% of patients who developed recurrent tumor after combination therapy had a component of distant failure. The incidence of severe gastrointestinal or genitourinary tract complications was not different in the two treatment groups. However, the incidence of lymphedema was increased in patients who received adjuvant radiation therapy. Although adjuvant radiation therapy appears to be tolerated without a significant increase in serious complications, the extent to which it may improve local control rates and survival in high-risk patients appears to be limited. In view of the high incidence of distant metastases in high-risk patients, consideration should be given to adjuvant systemic chemotherapy in addition to radiation therapy.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>États-Unis</li>
</country>
</list>
<tree>
<country name="États-Unis">
<noRegion>
<name sortKey="Soisson, Andrew P" sort="Soisson, Andrew P" uniqKey="Soisson A" first="Andrew P." last="Soisson">Andrew P. Soisson</name>
</noRegion>
<name sortKey="Berchuck, Andrew" sort="Berchuck, Andrew" uniqKey="Berchuck A" first="Andrew" last="Berchuck">Andrew Berchuck</name>
<name sortKey="Clarke Pearson, Daniel L" sort="Clarke Pearson, Daniel L" uniqKey="Clarke Pearson D" first="Daniel L." last="Clarke-Pearson">Daniel L. Clarke-Pearson</name>
<name sortKey="Creasman, William T" sort="Creasman, William T" uniqKey="Creasman W" first="William T." last="Creasman">William T. Creasman</name>
<name sortKey="Montana, Gustavo" sort="Montana, Gustavo" uniqKey="Montana G" first="Gustavo" last="Montana">Gustavo Montana</name>
<name sortKey="Soper, John T" sort="Soper, John T" uniqKey="Soper J" first="John T." last="Soper">John T. Soper</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 00DB52 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 00DB52 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:F19985DBDAC8C2D380C119DFF422A88A3C64BF5B
   |texte=   Adjuvant radiotherapy following radical hysterectomy for patients with stage IB and IIA cervical cancer
}}

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024